Fatty acid metabolism in breast cancer subtypes
- PMID: 28412757
- PMCID: PMC5438746
- DOI: 10.18632/oncotarget.15494
Fatty acid metabolism in breast cancer subtypes
Abstract
Dysregulation of fatty acid metabolism is recognized as a component of malignant transformation in many different cancers, including breast; yet the potential for targeting this pathway for prevention and/or treatment of cancer remains unrealized. Evidence indicates that proteins involved in both synthesis and oxidation of fatty acids play a pivotal role in the proliferation, migration and invasion of breast cancer cells. The following essay summarizes data implicating specific fatty acid metabolic enzymes in the genesis and progression of breast cancer, and further categorizes the relevance of specific metabolic pathways to individual intrinsic molecular subtypes of breast cancer. Based on mRNA expression data, the less aggressive luminal subtypes appear to rely on a balance between de novo fatty acid synthesis and oxidation as sources for both biomass and energy requirements, while basal-like, receptor negative subtypes overexpress genes involved in the utilization of exogenous fatty acids. With these differences in mind, treatments may need to be tailored to individual subtypes.
Keywords: breast cancer; fatty acid metabolism; molecular subtype.
Conflict of interest statement
The author declares no conflicts of interest.
Figures

Similar articles
-
Expanding Roles of De Novo Lipogenesis in Breast Cancer.Int J Environ Res Public Health. 2021 Mar 30;18(7):3575. doi: 10.3390/ijerph18073575. Int J Environ Res Public Health. 2021. PMID: 33808259 Free PMC article. Review.
-
Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.Int J Oncol. 2004 Mar;24(3):591-608. Int J Oncol. 2004. PMID: 14767544
-
RNA interference-mediated silencing of the p53 tumor-suppressor protein drastically increases apoptosis after inhibition of endogenous fatty acid metabolism in breast cancer cells.Int J Mol Med. 2005 Jan;15(1):33-40. Int J Mol Med. 2005. PMID: 15583825
-
Metabolic Footprints and Molecular Subtypes in Breast Cancer.Dis Markers. 2017;2017:7687851. doi: 10.1155/2017/7687851. Epub 2017 Dec 24. Dis Markers. 2017. PMID: 29434411 Free PMC article. Review.
-
Modulation of tumor fatty acids, through overexpression or loss of thyroid hormone responsive protein spot 14 is associated with altered growth and metastasis.Breast Cancer Res. 2014 Dec 4;16(6):481. doi: 10.1186/s13058-014-0481-z. Breast Cancer Res. 2014. PMID: 25472762 Free PMC article.
Cited by
-
Crosstalk between Immune Checkpoint Modulators, Metabolic Reprogramming and Cellular Plasticity in Triple-Negative Breast Cancer.Curr Oncol. 2022 Sep 23;29(10):6847-6863. doi: 10.3390/curroncol29100540. Curr Oncol. 2022. PMID: 36290817 Free PMC article. Review.
-
Metabolism and immunity in breast cancer.Front Med. 2021 Apr;15(2):178-207. doi: 10.1007/s11684-020-0793-6. Epub 2020 Oct 19. Front Med. 2021. PMID: 33074528 Review.
-
The Role for Myc in Coordinating Glycolysis, Oxidative Phosphorylation, Glutaminolysis, and Fatty Acid Metabolism in Normal and Neoplastic Tissues.Front Endocrinol (Lausanne). 2018 Apr 12;9:129. doi: 10.3389/fendo.2018.00129. eCollection 2018. Front Endocrinol (Lausanne). 2018. PMID: 29706933 Free PMC article. Review.
-
Lipid Droplet Biosynthesis Impairment through DGAT2 Inhibition Sensitizes MCF7 Breast Cancer Cells to Radiation.Int J Mol Sci. 2021 Sep 18;22(18):10102. doi: 10.3390/ijms221810102. Int J Mol Sci. 2021. PMID: 34576263 Free PMC article.
-
SDPR Inhibits TGF-β Induced Cancer Metastasis Through Fatty Acid Oxidation Regulation in Gastric Cancer.Int J Biol Sci. 2023 Jun 4;19(10):2999-3014. doi: 10.7150/ijbs.83012. eCollection 2023. Int J Biol Sci. 2023. PMID: 37416765 Free PMC article.
References
-
- Parker JS, Mullins M, Cheang MCU, Leung S, Voduc D, Vickery T, Davies S, Fauron C, He X, Hu Z, Quackenbush JF, Stijleman IJ, Palazzo J, et al. Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes. Journal of Clinical Oncology. 2009;27:1160–7. doi: 10.1200/jco.2008.18.1370. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical